<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-23-02</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-23-1-2</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Seizure Disorders</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Effect of Febrile Seizures on Oxidant Status</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Ann &#x0026; Robert H. Lurie Children&#x0027;s Hospital of Chicago, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>01</month>
<year>2009</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>12</month>
<year>2015</year>
</pub-date>
<volume>23</volume>
<issue>1</issue>
<fpage>2</fpage>
<lpage>3</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2009 The Author(s)</copyright-statement>
<copyright-year>2009</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1016/j.pediatrneurol.2008.09.006" vol="40" page="47">
<article-title>Oxidant status in children after febrile seizures</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>Erythrocyte malondialdehyde (EMA), glutathione peroxidase (GPO), and superoxide dismutase (SDM) levels were assessed in 31 children with a febrile seizure and 30 without, in a study at Dokuz Eylul University, Izmir, Turkey.</p>
</abstract>
<kwd-group>
<kwd>Oxidative Stress</kwd>
<kwd>Antioxidant Enzyme Levels</kwd>
<kwd>Brain Cell</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Erythrocyte malondialdehyde (EMA), glutathione peroxidase (GPO), and superoxide dismutase (SDM) levels were assessed in 31 children with a febrile seizure and 30 without, in a study at Dokuz Eylul University, Izmir, Turkey. Febrile seizures were simple in 25 (80%) and complex in 6 (20%) patients. EMA and GPO levels were significantly higher and SDM significantly lower in the febrile seizure group. Levels were not different in the simple and complex seizure groups. Changes in antioxidant enzyme levels are evidence of oxidative stress that may lead to brain cell damage following febrile seizures. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<p>COMMENT. The authors conclude that the oxidant-antioxidant balance is disturbed in children with febrile seizures, and changes in lipid peroxidation and level of antioxidant enzymes may result in neuronal cell damage after febrile seizures. That febrile seizures may be less benign than generally assumed, as suggested by this study, is also apparent from a recent report of MRI abnormalities that followed both simple and complex febrile seizures [<xref ref-type="bibr" rid="CIT0002">2</xref>], and an increased risk of sudden unexpected death during 2 years after a first febrile seizure (<bold>Ped Neur Briefs</bold> 2008;22:47-48 and 68-69) [<xref ref-type="bibr" rid="CIT0003">3</xref>]. Recommendations for the management of febrile seizures are outlined in a report of the Italian League Against Epilepsy [<xref ref-type="bibr" rid="CIT0004">4</xref>], with reference to the AAP Guidelines 1996, 1999, and to [<xref ref-type="bibr" rid="CIT0005">5</xref>]. The possible benefits of prolonged antiepileptic therapy to prevent recurrence of febrile seizures must be weighed against the reported adverse cognitive effects. Currently, chronic prophylactic treatment is usually discouraged, except in some patients with recurrent complex febrile seizures. More effective antipyretic treatment, rapid viral testing and antiviral therapy should provide a more specific approach to the prevention of recurrence of febrile seizures. [<xref ref-type="bibr" rid="CIT0006">6</xref>]</p>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>G&#252;nes</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dirik</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Yis</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Se&#231;kin</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kuralay</surname>
<given-names>F</given-names>
</name>
<name>
<surname>K&#246;se</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Oxidant status in children after febrile seizures</article-title>
<source>Pediatr Neurol</source>
<year>2009</year>
<month>Jan</month>
<volume>40</volume>
<issue>1</issue>
<fpage>47</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2008.09.006</pub-id>
<pub-id pub-id-type="pmid">19068254</pub-id>
</element-citation>
</ref>
<ref id="CIT0002">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hesdorffer</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Allen Hauser</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Dayan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Leary</surname>
<given-names>LD</given-names>
</name>
<etal/>
</person-group>
<article-title>Are MRI-detected brain abnormalities associated with febrile seizure type?</article-title>
<source>Epilepsia</source>
<year>2008</year>
<month>May</month>
<volume>49</volume>
<issue>5</issue>
<fpage>765</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="pmid">18070090</pub-id>
</element-citation>
</ref>
<ref id="CIT0003">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vestergaard</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pedersen</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Ostergaard</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Pedersen</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Olsen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Christensen</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Death in children with febrile seizures: a population-based cohort study</article-title>
<source>Lancet</source>
<year>2008</year>
<month>Aug</month>
<day>9</day>
<volume>372</volume>
<issue>9637</issue>
<fpage>457</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(08)61198-8</pub-id>
<pub-id pub-id-type="pmid">18692714</pub-id>
</element-citation>
</ref>
<ref id="CIT0004">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Capovilla</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Mastrangelo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Romeo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vigevano</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Recommendations for the management of &#x201C;febrile seizures&#x201D;: Ad Hoc Task Force of LICE Guidelines Commission</article-title>
<source>Epilepsia</source>
<year>2009</year>
<month>Jan</month>
<volume>50</volume>
<supplement>Suppl 1</supplement>
<fpage>2</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1111/j.1528-1167.2008.01963.x</pub-id>
<pub-id pub-id-type="pmid">19125841</pub-id>
</element-citation>
</ref>
<ref id="CIT0005">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukuyama</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Seki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ohtsuka</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Miura</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hara</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Practical guidelines for physicians in the management of febrile seizures</article-title>
<source>Brain Dev</source>
<year>1996</year>
<month>Nov-Dec</month>
<volume>18</volume>
<issue>6</issue>
<fpage>479</fpage>
<lpage>84</lpage>
<pub-id pub-id-type="pmid">8980847</pub-id>
</element-citation>
</ref>
<ref id="CIT0006">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Millichap</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Millichap</surname>
<given-names>JG</given-names>
</name>
</person-group>
<article-title>Empiric use of antibiotics for treatment of respiratory infection and febrile seizures</article-title>
<source>J Infect Dis</source>
<year>2008</year>
<month>Oct</month>
<day>1</day>
<volume>198</volume>
<issue>7</issue>
<fpage>1093</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1086/591464</pub-id>
<pub-id pub-id-type="pmid">18774887</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
